Figure 2.
Survival rates among eligible patients who underwent randomization after 5 cycles of CHOP/CHOP-R to either CHOP/CHOP-R ×3 or CHOP/CHOP-R ×1 with an ASCT, according to IPI risk category. Reprinted from Stiff et al13 with permission.
Survival rates among eligible patients who underwent randomization after 5 cycles of CHOP/CHOP-R to either CHOP/CHOP-R ×3 or CHOP/CHOP-R ×1 with an ASCT, according to IPI risk category. Reprinted from Stiff et al13 with permission.
